SLC13A5-IN-1

SLC13A5-IN-1 is a selective sodium-citrate co-transporter (SLC13A5) inhibitor. SLC13A5-IN-1 completely blocks the uptake of 14C-citrate with an IC50 value of 0.022 μM in HepG2 cells. SLC13A5-IN-1 has the potential for the treatment of metabolic and/or cardiovascular diseases. SLC13A5-IN-1 is extracted from patent WO2018104220A1, Compound I-5.


Cat. No.: EX-A7538	Purity: >98%

	Chemical structure of SLC13A5-IN-1

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
5mg	350	In-stock
10mg	500	In-stock
25mg	800	In-stock
50mg	1250	In-stock
100mg	1950	In-stock
200mg	2850	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	2227548-95-8
Purity	>98%
Formula	C19H19Cl3N2O3S
Mol Weight	461.79
Color	White to off-white
State	solid powder
Solubility	DMSO : 12.5 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder -20℃ 3 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Joerg Kley, et al. Sulfonamides as inhibitors of the uptake of extracellular citrate. Patent WO2018104220A1
CoA	CoA of SLC13A5-IN-1


		Search